Medicare Enrolled
Dr. Deidra Bobincheck, NP-C
Registered Nurse · Euclid, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bobincheck from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bobincheck?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bobincheck
Dr. Deidra Bobincheck is a registered nurse in Euclid, OH, with 12 years of NPI registration. Based on federal Medicare data, Dr. Bobincheck performed 704 Medicare services across 417 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bobincheck received a total of $13,420 from 61 pharmaceutical and/or device companies across 724 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in registered nurse. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bobincheck is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 9% volume in OH
$13,420 industry payments
Medicare Practice Summary
Medicare Utilization ↗704
Medicare services
Top 9% in OH for registered nurse
417
Unique beneficiaries
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~59 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
226 | $78 | $166 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
133 | $51 | $111 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
74 | $36 | $95 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
53 | $112 | $322 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
45 | $67 | $202 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
40 | $45 | $119 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
37 | $75 | $165 |
| Behavioral health care management, 20+ minutes This service involves clinical staff time directed by a healthcare professional to manage behavioral health conditions. It requires at least 20 minutes of dedicated clinical staff time. |
34 | $24 | $73 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
26 | $140 | $419 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
21 | $9 | $25 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
15 | $53 | $112 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,420
Total received (2021-2024)
Avg $3,355/year across 4 years
Top 1% in OH for registered nurse
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
724
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,420 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,382
2023
$3,725
2022
$3,119
2021
$3,194
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$413
GlaxoSmithKline, LLC.
$334
PFIZER INC.
$242
Otsuka America Pharmaceutical, Inc.
$235
Phathom Pharmaceuticals, Inc.
$187
E.R. Squibb & Sons, L.L.C.
$187
Novo Nordisk Inc
$170
ABBVIE INC.
$149
Lundbeck LLC
$145
Lilly USA, LLC
$141
Abbott Laboratories
$139
Bayer Healthcare Pharmaceuticals Inc.
$135
Exact Sciences Corporation
$102
Novartis Pharmaceuticals Corporation
$72
Axsome Therapeutics, Inc.
$71
Amgen Inc.
$70
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$59
Optinose US, Inc.
$58
Janssen Pharmaceuticals, Inc
$47
Dexcom, Inc.
$42
Sumitomo Pharma America, Inc.
$40
Alkermes, Inc.
$37
AIMMUNE THERAPEUTICS, INC.
$35
VIVUS LLC
$34
Eisai Inc.
$32
Vanda Pharmaceuticals Inc.
$29
MERZ NORTH AMERICA, INC.
$24
Xeris Pharmaceuticals, Inc.
$23
Takeda Pharmaceuticals U.S.A., Inc.
$21
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$21
Neurocrine Biosciences, Inc.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
Seqirus USA Inc
$17
Teva Pharmaceuticals USA, Inc.
$16
Alexion Pharmaceuticals, Inc.
$15
Top 3 companies account for 29.3% of 2024 payments
All-time payments by company (2021-2024) ›
GlaxoSmithKline, LLC.
$1,240
AstraZeneca Pharmaceuticals LP
$1,138
Lilly USA, LLC
$1,070
PFIZER INC.
$948
Novo Nordisk Inc
$847
ABBVIE INC.
$838
Otsuka America Pharmaceutical, Inc.
$584
E.R. Squibb & Sons, L.L.C.
$477
Novartis Pharmaceuticals Corporation
$416
AbbVie Inc.
$413
Amgen Inc.
$360
ITI, Inc.
$310
Boehringer Ingelheim Pharmaceuticals, Inc.
$269
Abbott Laboratories
$267
SANOFI-AVENTIS U.S. LLC
$229
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$211
Lundbeck LLC
$209
Exact Sciences Corporation
$208
Axsome Therapeutics, Inc.
$197
Bayer Healthcare Pharmaceuticals Inc.
$193
Sunovion Pharmaceuticals Inc.
$190
Phathom Pharmaceuticals, Inc.
$187
Merz North America, Inc.
$176
Merck Sharp & Dohme LLC
$163
VIVUS LLC
$152
Bayer HealthCare Pharmaceuticals Inc.
$149
Alkermes, Inc.
$146
Mylan Specialty L.P.
$135
Janssen Pharmaceuticals, Inc
$128
Merck Sharp & Dohme Corporation
$123
Takeda Pharmaceuticals U.S.A., Inc.
$114
Sumitomo Pharma America, Inc.
$114
Nestle HealthCare Nutrition Inc.
$110
Dexcom, Inc.
$98
Teva Pharmaceuticals USA, Inc.
$72
Horizon Therapeutics plc
$66
Amarin Pharma Inc.
$65
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$59
Optinose US, Inc.
$58
Alexion Pharmaceuticals, Inc.
$57
UCB, Inc.
$50
Astellas Pharma US Inc
$48
Biohaven Pharmaceuticals, Inc.
$47
Xeris Pharmaceuticals, Inc.
$43
SCILEX PHARMACEUTICALS INC.
$40
Neurocrine Biosciences, Inc.
$38
Paratek Pharmaceuticals, Inc.
$38
AIMMUNE THERAPEUTICS, INC.
$35
Eisai Inc.
$32
DEXCOM, INC.
$32
Nabriva Therapeutics, plc
$30
Vanda Pharmaceuticals Inc.
$29
MERZ NORTH AMERICA, INC.
$24
Ardelyx, Inc.
$22
Radius Health, Inc.
$21
Biohaven Pharmaceutical Holding Company Ltd.
$20
Avanir Pharmaceuticals, Inc.
$20
Biogen, Inc.
$19
Seqirus USA Inc
$17
Ultragenyx Pharmaceutical Inc.
$15
Esperion Therapeutics, Inc.
$13
Top 3 companies account for 25.7% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · AIMOVIG · AIRSUPRA · ANORO ELLIPTA · APTIOM · AREXVY · ARISTADA · AUSTEDO · AirDuo Digihaler · Austedo XR · Auvelity · BAQSIMI · BELSOMRA · BREZTRI · Briviact · CAPLYTA · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CREON · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · DIFICID · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Fluad · FreeStyle Libre 2 · GEMTESA · GVOKE HYPOPEN · HETLIOZ · IBSRELA · INVEGA SUSTENNA · JANUVIA · JARDIANCE · JYNARQUE · KRYSTEXXA · Kerendia · LEQVIO · LINZESS · LOKELMA · LONHALA MAGNAIR · LYBALVI · Leqembi · MOUNJARO · MYRBETRIQ · Myrbetriq · NEXLETOL · NUEDEXTA · NURTEC ODT · NUZYRA · OFEV · Ongentys · Otezla · Ozempic · PAXLOVID · PREVNAR 13 · PREVNAR 20 · Prolia · QSYMIA · QULIPTA · Qsymia · REXULTI · REYVOW · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SPRAVATO · STIOLTO RESPIMAT · STRENSIQ · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tymlos · UBRELVY · ULTOMIRIS · VERQUVO · VIBERZI · VOQUEZNA · VRAYLAR · VYNDAMAX · VYVANSE · Vascepa · Wegovy · XARELTO · XIFAXAN · Xenleta · Xeomin · Xhance · YUPELRI · Yupelri · ZENPEP · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for registered nurse in OH.
Geographic Context
Registered nurses within 10 mi
1,897
Per 100K population
151.8
County median income
$62,823
Nearest hospital
EUCLID HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bobincheck is a clinical cardiology specialist, with above-average Medicare volume (top 9% in OH), with low-engagement industry engagement in the top 1% of OH peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bobincheck experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Bobincheck performed 226 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bobincheck receive payments from pharmaceutical companies?
Yes. Dr. Bobincheck received a total of $13,420 from 61 companies across 724 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bobincheck's costs compare to other registered nurses in Euclid?
Dr. Bobincheck's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bobincheck) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Registered Nurses in Euclid
Browse registered nurses in Euclid ranked by procedure volume and transparency data.
Highest volume
Top Registered Nurses in OH
Registered nurses ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Registered Nurses in OH
Which OH registered nurses receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology